Revvity is a global leader in developing and delivering technologies and solutions across disease pathways, focused on advancing health science and human potential. They develop cutting-edge technologies in areas like biomarker identification, multi-omics, diagnostics, and informatics, supporting critical processes from disease research to diagnostics and treatment. Serving over 2 million scientists and operating in 190 countries, Revvity aims to accelerate scientific breakthroughs that address significant health challenges.
£1 Billion Investment to Get Britain Working: How to Maximise ROI in Employment Support
Chief Impact Officer at Shaw Trust, Julie Leonard, outlines how the Government’s £1 billion investment in employment support can deliver stronger returns for taxpayers by backing evidence-based, health-linked approaches like Individual Placement and Support (IPS).


